Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| YS Biopharma Company Ltd | YS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.02 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.02 | 1.02 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.3503 - 1.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 1.02 | USD |
YS Biopharma Company Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.38M | 93.06M | - | 687.2M | -283.47M | -3.05 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
YS Biopharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 1.03 | 1.10 | 0.881 | 0.9756417 | 58,611 | -0.01 | -0.97% |
| 3 Months | 0.63 | 1.10 | 0.58 | 0.8500705 | 124,263 | 0.39 | 61.90% |
| 6 Months | 0.5272 | 1.10 | 0.3503 | 0.5958348 | 170,662 | 0.4928 | 93.47% |
| 1 Year | 1.40 | 1.75 | 0.3503 | 1.07 | 367,223 | -0.38 | -27.14% |
| 3 Years | 12.67 | 12.93 | 0.3503 | 1.39 | 551,984 | -11.65 | -91.95% |
| 5 Years | 12.67 | 12.93 | 0.3503 | 1.39 | 551,984 | -11.65 | -91.95% |
YS Biopharma Description
| YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China. |
